Literature DB >> 21175107

Shift work, light at night, and the risk of breast cancer.

Virginia A Reed1.   

Abstract

Studies of the effect of shift work have identified several negative health outcomes, most notably breast cancer. Disruption of circadian rhythm by exposure to light at night has been identified as the mechanism likely responsible for this outcome. This article recommends that health care institutions work with occupational health nurses to develop and implement hazard communication and policies concerning shift work, exposure to light at night, and increased risk for negative health outcomes, particularly breast cancer. 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 21175107     DOI: 10.3928/08910162-20101216-01

Source DB:  PubMed          Journal:  AAOHN J        ISSN: 0891-0162


  5 in total

Review 1.  Sleep, immunity and inflammation in gastrointestinal disorders.

Authors:  Tauseef Ali; James Choe; Ahmed Awab; Theodore L Wagener; William C Orr
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Circadian Regulation of Benzo[a]Pyrene Metabolism and DNA Adduct Formation in Breast Cells and the Mouse Mammary Gland.

Authors:  Emily E Schmitt; Rola Barhoumi; Richard P Metz; Weston W Porter
Journal:  Mol Pharmacol       Date:  2016-12-22       Impact factor: 4.436

3.  Disruption of circadian rhythms: a crucial factor in the etiology of depression.

Authors:  Roberto Salgado-Delgado; Araceli Tapia Osorio; Nadia Saderi; Carolina Escobar
Journal:  Depress Res Treat       Date:  2011-08-08

4.  Mismatch between perceived family and individual chronotype and their association with sleep-wake patterns.

Authors:  Angela J Pereira-Morales; Ana Adan; Leandro P Casiraghi; Andrés Camargo
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

5.  Self-reported sleep quality as prognostic for survival in lung cancer patients.

Authors:  Teodor Gottfried; Iris Kamer; Iris Salant; Damien Urban; Yaacov R Lawrence; Amir Onn; Jair Bar
Journal:  Cancer Manag Res       Date:  2020-01-15       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.